HEGLN (Dalian) Pharmaceutical Co., Ltd was officially established on 18 December 2008. This company is a R&D, production and sales in one biological engineering pharmaceutical enterprise. With a total investment of 830 million Yuan, it mainly produces enzyme engineering drugs, special pharmaceutical preparations, biological gene-based drugs, chemicals and medical equipment. It established an R&D center, building a new medical product industrial base.